Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 204

Similar articles for PubMed (Select 23360797)

1.

NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells.

Garipov A, Li H, Bitler BG, Thapa RJ, Balachandran S, Zhang R.

Mol Cancer Res. 2013 Apr;11(4):360-9. doi: 10.1158/1541-7786.MCR-12-0661. Epub 2013 Jan 29.

2.

Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells.

Li H, Cai Q, Godwin AK, Zhang R.

Mol Cancer Res. 2010 Dec;8(12):1610-8. doi: 10.1158/1541-7786.MCR-10-0398. Epub 2010 Nov 29.

3.

SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK.

Li H, Cai Q, Wu H, Vathipadiekal V, Dobbin ZC, Li T, Hua X, Landen CN, Birrer MJ, Sánchez-Beato M, Zhang R.

Mol Cancer Res. 2012 Nov;10(11):1462-72. doi: 10.1158/1541-7786.MCR-12-0335. Epub 2012 Sep 10.

4.

ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches.

Li H, Bitler BG, Vathipadiekal V, Maradeo ME, Slifker M, Creasy CL, Tummino PJ, Cairns P, Birrer MJ, Zhang R.

Cancer Prev Res (Phila). 2012 Mar;5(3):484-91. doi: 10.1158/1940-6207.CAPR-11-0414. Epub 2011 Dec 5.

5.

The role of EZH2 and DNA methylation in hMLH1 silencing in epithelial ovarian cancer.

Wang J, Yu L, Cai J, Jia J, Gao Y, Liang M, Wang Z.

Biochem Biophys Res Commun. 2013 Apr 19;433(4):470-6. doi: 10.1016/j.bbrc.2013.03.037. Epub 2013 Mar 21.

PMID:
23523787
6.

MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹).

Semaan A, Qazi AM, Seward S, Chamala S, Bryant CS, Kumar S, Morris R, Steffes CP, Bouwman DL, Munkarah AR, Weaver DW, Gruber SA, Batchu RB.

Pharm Res. 2011 Dec;28(12):3079-90. doi: 10.1007/s11095-011-0547-x. Epub 2011 Aug 5.

PMID:
21818714
7.

Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence.

Bitler BG, Nicodemus JP, Li H, Cai Q, Wu H, Hua X, Li T, Birrer MJ, Godwin AK, Cairns P, Zhang R.

Cancer Res. 2011 Oct 1;71(19):6184-94. doi: 10.1158/0008-5472.CAN-11-1341. Epub 2011 Aug 4.

8.

EZH2 participates in malignant biological behavior of epithelial ovarian cancer through regulating the expression of BRCA1.

Li T, Cai J, Ding H, Xu L, Yang Q, Wang Z.

Cancer Biol Ther. 2014 Mar 1;15(3):271-8. doi: 10.4161/cbt.27306. Epub 2013 Dec 12.

9.

EZH2 blockade by RNA interference inhibits growth of ovarian cancer by facilitating re-expression of p21(waf1/cip1) and by inhibiting mutant p53.

Seward S, Semaan A, Qazi AM, Gruzdyn OV, Chamala S, Bryant CC, Kumar S, Cameron D, Sethi S, Ali-Fehmi R, Morris R, Bouwman DL, Munkarah AR, Weaver DW, Gruber SA, Batchu RB.

Cancer Lett. 2013 Aug 9;336(1):53-60. doi: 10.1016/j.canlet.2013.04.012. Epub 2013 Apr 18.

PMID:
23603558
10.

Role of EZH2 in Epithelial Ovarian Cancer: From Biological Insights to Therapeutic Target.

Li H, Zhang R.

Front Oncol. 2013 Mar 13;3:47. doi: 10.3389/fonc.2013.00047. eCollection 2013.

11.

Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer.

Gaudin F, Nasreddine S, Donnadieu AC, Emilie D, Combadière C, Prévot S, Machelon V, Balabanian K.

PLoS One. 2011;6(7):e21546. doi: 10.1371/journal.pone.0021546. Epub 2011 Jul 7.

12.

The CCAAT box binding transcription factor, nuclear factor-Y (NF-Y) regulates transcription of human aldo-keto reductase 1C1 (AKR1C1) gene.

Pallai R, Simpkins H, Chen J, Parekh HK.

Gene. 2010 Jul 1;459(1-2):11-23. doi: 10.1016/j.gene.2010.03.006. Epub 2010 Mar 23.

13.

Three-dimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition.

Amatangelo MD, Garipov A, Li H, Conejo-Garcia JR, Speicher DW, Zhang R.

Cell Cycle. 2013 Jul 1;12(13):2113-9. doi: 10.4161/cc.25163. Epub 2013 Jun 10.

14.

ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.

Llauradó M, Abal M, Castellví J, Cabrera S, Gil-Moreno A, Pérez-Benavente A, Colás E, Doll A, Dolcet X, Matias-Guiu X, Vazquez-Levin M, Reventós J, Ruiz A.

Int J Cancer. 2012 Apr 1;130(7):1532-43. doi: 10.1002/ijc.26148. Epub 2011 Aug 12.

PMID:
21520040
15.

Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.

Peng DX, Luo M, Qiu LW, He YL, Wang XF.

Oncol Rep. 2012 Apr;27(4):1238-44. doi: 10.3892/or.2012.1625. Epub 2012 Jan 11.

16.

An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response.

Pinciroli P, Alberti C, Sensi M, Canevari S, Tomassetti A.

BMC Genomics. 2013 Jul 26;14:508. doi: 10.1186/1471-2164-14-508.

17.

KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.

Huang L, Wang HY, Li JD, Wang JH, Zhou Y, Luo RZ, Yun JP, Zhang Y, Jia WH, Zheng M.

Cell Death Dis. 2013 Aug 1;4:e745. doi: 10.1038/cddis.2013.256.

18.

Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo.

Hu S, Yu L, Li Z, Shen Y, Wang J, Cai J, Xiao L, Wang Z.

Cancer Biol Ther. 2010 Oct 15;10(8):788-95. Epub 2010 Oct 15.

19.

EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells.

Mu Z, Li H, Fernandez SV, Alpaugh KR, Zhang R, Cristofanilli M.

J Exp Clin Cancer Res. 2013 Sep 27;32:70. doi: 10.1186/1756-9966-32-70.

20.

Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.

Wang ZQ, Bachvarova M, Morin C, Plante M, Gregoire J, Renaud MC, Sebastianelli A, Bachvarov D.

Oncotarget. 2014 Jan 30;5(2):544-60.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk